Neural stem cell therapy for MS is still in its infancy. It is being studied for progressive MS and differs from the already known autologous hematopoietic stem cell therapy. This is already used for MS, albeit not very often.
In Germany, a task force has been formed to offer autologous stem cell therapy to more patients. However, it works best in younger patients with not very long disease duration and highly active MS.
Prof. Mathias Mäurer explains in this video what distinguishes the two forms of stem cell therapy and who benefits from it. In April 2023, Prof. Mäurer had already reported on the neural stem cell therapy.
Please consider using the automated translation of YouTube. You can activate this function by clicking on the settings symbol and choosing subtitles.
